Fengnan Niu

504 total citations
21 papers, 418 citations indexed

About

Fengnan Niu is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Fengnan Niu has authored 21 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Clinical Biochemistry. Recurrent topics in Fengnan Niu's work include Mitochondrial Function and Pathology (4 papers), Alzheimer's disease research and treatments (3 papers) and Metabolism and Genetic Disorders (3 papers). Fengnan Niu is often cited by papers focused on Mitochondrial Function and Pathology (4 papers), Alzheimer's disease research and treatments (3 papers) and Metabolism and Genetic Disorders (3 papers). Fengnan Niu collaborates with scholars based in China, United States and France. Fengnan Niu's co-authors include Yun Xu, Xin Zhang, Leilei Chang, Danqing Huang, Zhibin Chen, Erguang Li, Dening Guan, Bing Zhang, Yun Luo and Xin Zhang and has published in prestigious journals such as PLoS ONE, Journal of Cerebral Blood Flow & Metabolism and Life Sciences.

In The Last Decade

Fengnan Niu

20 papers receiving 414 citations

Peers

Fengnan Niu
Comparison fields: 5 of 116
  • Molecular Biology 163
  • Neurology 80
  • Physiology 75
  • Cellular and Molecular Neuroscience 62
  • Epidemiology 43
Replace Yingna Li with:
Yingna Li China
Jing Zheng China
Pengxiang Zhu Japan
Anne Cantereau France
Chenzhuo Feng China
Radhika Patnala Singapore
Maryam F. Afzali United States
Stefania Zampatti Italy
Yingna Li China View profile →
Citations per field, relative to Fengnan Niu
Fengnan Niu · 1×
Citations per year, relative to Fengnan Niu
Fengnan Niu · 1×

Countries citing papers authored by Fengnan Niu

Since Specialization
Citations

This map shows the geographic impact of Fengnan Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengnan Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengnan Niu more than expected).

Fields of papers citing papers by Fengnan Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengnan Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengnan Niu. The network helps show where Fengnan Niu may publish in the future.

Co-authorship network of co-authors of Fengnan Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengnan Niu. A scholar is included among the top collaborators of Fengnan Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengnan Niu. Fengnan Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 4
3 1
4 0
5 1
6 4
7 2
8 4
9 19
10 24
11 12
12 3
13 107
14 6
15 4
16 33
17 66
18 78
19 17
20 27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026